{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:10:49Z","timestamp":1774793449835,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T00:00:00Z","timestamp":1037318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2003,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MTHFR is a critical enzyme that regulates the metabolism of folate and methionine, both of which are important factors in DNA methylation and synthesis. Subjects with the 677C\u2192T variant have impaired remethylation of Hcy to methionine that could determine hyperhomocysteinemia. Remethylation of Hcy into methionine and DNA methylation are also affected by MTX treatment. Thus, a combined effect between MTX and reduced activity of the <jats:italic>MTHFR<\/jats:italic> 677C\u2192T polymorphism could occur, leading to toxicity. In a clinical trial, 43 ovarian cancer patients were treated with low doses of MTX. During MTX therapy, 12 patients (27.9%) developed G3\/4 WHO toxicity. In these 12 patients, we observed 6 G3\/4 thrombocytopenias, 1 G3 neutropenia, 1 G3 anemia, 9 G3 mucositis cases and 1 G4 mucositis case. A significant association was observed between toxicity and TT <jats:italic>MTHFR<\/jats:italic> 677 genotype (<jats:italic>p<\/jats:italic> &lt; 0.0001). G3\/4 toxicity occurred in 10 of 13 (77%), 1 of 17 (6%) and 1 of 13 (8%) patients with the TT, CT and CC <jats:italic>MTHFR<\/jats:italic> genotypes, respectively. According to the logistic regression model, patients with the TT genotype had a relative risk of 42.0 (95% CI 4.2\u2013418.6) of developing G3\/4 toxicity compared to patients with the CC and CT genotypes. Patients with the TT genotype had Hcy plasma levels after MTX therapy significantly (<jats:italic>p<\/jats:italic> = 0.0001) higher than basal levels (mean \u00b1 SD = 16.71 \u00b1 4.72 <jats:italic>vs.<\/jats:italic> 12.48 \u00b1 3.57 \u03bcmol\/l); moreover, they also had higher Hcy plasma levels after MTX than patients with other <jats:italic>MTHFR<\/jats:italic> 677 genotypes (CC mean \u00b1 SD = 9.87 \u00b1 3.61 \u03bcmol\/l and CT mean \u00b1 SD = 11.48 \u00b1 3.13 \u03bcmol\/l). Finally, significant associations were observed between G3\/4 WHO toxicity and higher Hcy plasma levels after MTX treatment (<jats:italic>p<\/jats:italic> = 0.0004). In conclusion, our data suggest that the TT <jats:italic>MTHFR<\/jats:italic> 677 genotype is associated with marked MTX\u2010induced hyperhomocysteinemia and could represent a pharmacogenetic marker for toxicity after chronic treatment with low doses of MTX. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.10847","type":"journal-article","created":{"date-parts":[[2002,12,9]],"date-time":"2002-12-09T13:47:10Z","timestamp":1039441630000},"page":"294-299","source":"Crossref","is-referenced-by-count":105,"title":["Effect of methylenetetrahydrofolate reductase 677C\u2192T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients"],"prefix":"10.1002","volume":"103","author":[{"given":"Giuseppe","family":"Toffoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Tumolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Mini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Boiocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,11,15]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nu.05.070185.000555"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01675-8"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.23.2520"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91743-8"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79188-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.061408298"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010920)95:5<332::AID-IJC1058>3.0.CO;2-9"},{"key":"e_1_2_5_10_2","first-page":"3272","article-title":"Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population","volume":"61","author":"Song C","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_5_11_2","first-page":"659","article-title":"Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene\u2013environment interaction?","volume":"8","author":"Ulrich CM","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-725-3_3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.3.3.299"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.062066299"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(82)90012-7"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(02)70209-1"},{"key":"e_1_2_5_17_2","first-page":"5879","article-title":"Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions","volume":"49","author":"Broxson EH","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_5_18_2","first-page":"828","article-title":"Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate","volume":"51","author":"Refsum H","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-725-3_2"},{"key":"e_1_2_5_20_2","volume-title":"WHO handbook for reporting results of cancer treatment","author":"World Health Organisation","year":"1979"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80438-3"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008337900349"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.231"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200204000-00002"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.10.4.8647346"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.8.2800"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.2.79"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.10847","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.10847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T14:53:09Z","timestamp":1697295189000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.10847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,15]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,1,20]]}},"alternative-id":["10.1002\/ijc.10847"],"URL":"https:\/\/doi.org\/10.1002\/ijc.10847","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,15]]}}}